New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
Clinical trial NCT00393952 · COMPLETED
Trial details
- NCT number
- NCT00393952
- Sponsor
- SkyePharma AG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2008-04-01
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.